Brier, WA, United States of America

Cathy E Lofton-Day

This inventor holds 2 USPTO granted patents. Top assignee: Epigenomics Ag. Active years: 2007-2014.


% Patents Active = 50.0

Average Co-Inventor Count = 3.3

ph-index = 2

Forward Citations = 13(Granted Patents)


Location History:

  • Brier, WA (US) (2007)
  • Seattle, WA (US) (2014)

Company Filing History:


Years Active: 2007-2014

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Cathy E Lofton-Day: Innovator in Methylation Analysis

Introduction

Cathy E Lofton-Day is a prominent inventor based in Brier, WA (US). She has made significant contributions to the field of methylation analysis, holding 2 patents that focus on innovative methods for analyzing DNA.

Latest Patents

Her latest patents include a method for methylation analysis, which relates to compositions and methods for providing DNA suitable for reference laboratories. This invention emphasizes the highly specific and sensitive methylation analysis of the Septin 9 gene. Another notable patent is for discovery and diagnostic methods using 5-methylcytosine DNA glycosylase. This invention provides methods for identifying methylated CpG dinucleotides in genomic DNA sequences and comparing the methylation status between normal and diseased genomic DNA.

Career Highlights

Cathy E Lofton-Day is associated with Epigenomics AG, where she continues to advance research in the field of epigenetics. Her work has been instrumental in developing methods that enhance the understanding of DNA methylation and its implications in health and disease.

Collaborations

Cathy collaborates with notable colleagues, including John K Day and Theo Devos, contributing to a dynamic research environment that fosters innovation.

Conclusion

Cathy E Lofton-Day's contributions to methylation analysis exemplify her dedication to advancing scientific knowledge and improving diagnostic methods. Her work continues to impact the field significantly.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…